https://www.prnewswire.com/news-releases/----------astana-genetic-center-30220658... | | JUL 25, 2024, 08:20 ET | | https://mma.prnewswire.com/media/2469085/1.jpg?w=300 | JUL 25, 2024, 08:20 ET
Новая эра в здравоохранении Казахстана: церемония открытия... | Новая эра в здравоохранении Казахстана: церемония открытия передовой генетической... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/------bgm0504----302204156.html | | JUL 23, 2024, 10:37 ET | | https://mma.prnewswire.com/media/2465893/image_5031720_25221542.jpg?w=300 | JUL 23, 2024, 10:37 ET
Разработанный ИИ и методом молекулярной динамики BGM0504 п... | Разработанный ИИ и методом молекулярной динамики BGM0504 показал отличную эффекти... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/-grunenthal--valinor-pharma-----250---30... | JUL 23, 2024, 13:22 ET
Компания Grünenthal приобретает Valinor Pharma за общую су... | JUL 23, 2024, 13:22 ET | | | JUL 23, 2024, 13:22 ET
Компания Grünenthal приобретает Valinor Pharma за общую су... | Компания Grünenthal приобретает Valinor Pharma за общую сумму около 250 млн долла... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/a-new-era-for-healthcare-in-kazakhstan-u... | | JUL 25, 2024, 08:04 ET | On July 18, BGI Genomics announced the opening of the Astana Genetic Center (AGC)... | https://mma.prnewswire.com/media/2469085/1.jpg?w=300 | JUL 25, 2024, 08:04 ET
A New Era for Healthcare in Kazakhstan: Unveiling Astana G... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/a-novel-way-to-reduce-alzheimers-amyloid... | | JUL 24, 2024, 03:00 ET | T3D Therapeutics, Inc., a clinical stage drug development company engaged in the ... | https://mma.prnewswire.com/media/2264861/T3D_Logo.jpg?w=300 | JUL 24, 2024, 03:00 ET
A Novel Way to Reduce Alzheimer's Amyloid Plaque Burden, P... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/abbvie-announces-european-commission-app... | | 02:00 ET | AbbVie (NYSE: ABBV) today announced that the European Commission has approved SKY... | https://mma.prnewswire.com/media/386913/AbbVie_logo.jpg?w=300 | 02:00 ET
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab)... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/abbvie-reports-second-quarter-2024-finan... | | JUL 25, 2024, 07:36 ET | AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June ... | https://mma.prnewswire.com/media/386913/AbbVie_logo.jpg?w=300 | JUL 25, 2024, 07:36 ET
AbbVie Reports Second-Quarter 2024 Financial Results | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/actinium-announces-fda-clearance-of-ioma... | | JUL 25, 2024, 08:45 ET | Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a... | https://mma.prnewswire.com/media/730678/Actinium_Pharmaceuticals_Logo.jpg?w=300 | JUL 25, 2024, 08:45 ET
Actinium Announces FDA Clearance of Iomab-ACT Targeted Con... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-to-present-at-t... | | JUL 25, 2024, 07:30 ET | Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a... | https://mma.prnewswire.com/media/730678/Actinium_Pharmaceuticals_Logo.jpg?w=300 | JUL 25, 2024, 07:30 ET
Actinium Pharmaceuticals to Present at the 3rd Annual Targ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/adme-toxicology-testing-market-worth-7-1... | | JUL 24, 2024, 06:26 ET | InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report... | https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg?w=300 | JUL 24, 2024, 06:26 ET
ADME Toxicology Testing Market Worth 7.12 Billion 2031- Re... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/alcami-unveils-new-conditions-and-servic... | | JUL 23, 2024, 09:00 ET | Alcami Corporation ("Alcami"), a leading contract development and manufacturing o... | https://mma.prnewswire.com/media/2466538/Alcami_Corporation_State_of_the_art_phar... | JUL 23, 2024, 09:00 ET
Alcami unveils new conditions and services at state-of-the... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/alkermes-plc-reports-second-quarter-2024... | | JUL 24, 2024, 07:00 ET | Alkermes plc (Nasdaq: ALKS) today reported financial results for the second quart... | https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg?w=300 | JUL 24, 2024, 07:00 ET
Alkermes plc Reports Second Quarter 2024 Financial Results... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/allucent-names-paula-brown-stafford-as-c... | | JUL 23, 2024, 07:02 ET | Allucent today announced that it has appointed industry veteran Paula Brown Staff... | https://mma.prnewswire.com/media/2466415/Allucent_CEO_Paula_Brown_Stafford.jpg?w=... | JUL 23, 2024, 07:02 ET
Allucent Names Paula Brown Stafford as CEO | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/amyotrophic-lateral-sclerosis-treatment-... | | JUL 23, 2024, 17:50 ET | The global amyotrophic lateral sclerosis treatment market size is estimated to gr... | https://mma.prnewswire.com/media/2466108/Technavio___Global_Amyotrophic_Lateral_S... | JUL 23, 2024, 17:50 ET
Amyotrophic Lateral Sclerosis Treatment Market size is set... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/anixa-biosciences-announces-fda-approval... | | JUL 23, 2024, 08:15 ET | Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnolog... | https://mma.prnewswire.com/media/602982/ITUS_Corporation_Logo.jpg?w=300 | JUL 23, 2024, 08:15 ET
Anixa Biosciences Announces FDA Approval of Individual Pat... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/apci-applauds-introduction-of-the-pharma... | | JUL 23, 2024, 11:26 ET | Officials with American Pharmacy Cooperative, Inc. (APCI) applauded the introduct... | https://mma.prnewswire.com/media/1749879/APCI_Logo.jpg?w=300 | JUL 23, 2024, 11:26 ET
APCI Applauds Introduction of the Pharmacists Fight Back A... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/ariceum-therapeutics-commences-phase-1-c... | JUL 25, 2024, 03:30 ET
Ariceum Therapeutics Commences Phase 1 Clinical Trial in P... | JUL 25, 2024, 03:30 ET | Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmac... | | JUL 25, 2024, 03:30 ET
Ariceum Therapeutics Commences Phase 1 Clinical Trial in P... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/aurora-receives-expanded-cultivation-and... | | JUL 25, 2024, 19:15 ET | Company's Long-Standing Investment in the Region Continues with Enhanced Local Pr... | https://mma.prnewswire.com/media/2469557/Aurora_Cannabis_Inc__Aurora_Receives_Exp... | JUL 25, 2024, 19:15 ET
Aurora Receives Expanded Cultivation and Unique Research L... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/bio-thera-solutions-initiates-integrated... | | JUL 25, 2024, 06:30 ET | Bio-Thera Solutions Inc. (688177: SH), a commercial-stage biopharmaceutical compa... | https://mma.prnewswire.com/media/2184516/Bio_Thera_Logo.jpg?w=300 | JUL 25, 2024, 06:30 ET
Bio-Thera Solutions Initiates Integrated Phase I / Phase I... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2024-fin... | | JUL 23, 2024, 08:00 ET | BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy,... | https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.jpg?w=30... | JUL 23, 2024, 08:00 ET
BioMarin to Host Second Quarter 2024 Financial Results Con... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/biovaxys-announces-issuance-of-dpx-relat... | | JUL 23, 2024, 08:00 ET | BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "C... | https://mma.prnewswire.com/media/1430981/4526799/BIOVAXYS_Logo.jpg?w=300 | JUL 23, 2024, 08:00 ET
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/calliditas-announces-positive-transform-... | 02:23 ET
Calliditas announces positive TRANSFORM Phase 2b topline data in primary... | 02:23 ET | Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today... | | 02:23 ET
Calliditas announces positive TRANSFORM Phase 2b topline data in primary... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/calliditas-announces-positive-transform-... | 02:29 ET
Calliditas announces positive TRANSFORM Phase 2b topline data in primary... | 02:29 ET | Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today... | | 02:29 ET
Calliditas announces positive TRANSFORM Phase 2b topline data in primary... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/capital-rx-receives-a-us-utility-patent-... | | JUL 23, 2024, 07:39 ET | Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit ... | https://mma.prnewswire.com/media/2239304/Capital_Rx_JUDI_Logo.jpg?w=300 | JUL 23, 2024, 07:39 ET
Capital Rx Receives a US Utility Patent Covering its Enter... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/cardinal-health-to-announce-fourth-quart... | | JUL 23, 2024, 06:45 ET | Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financia... | https://mma.prnewswire.com/media/2223684/Cardinal_Health_no_tagline_Logo.jpg?w=30... | JUL 23, 2024, 06:45 ET
Cardinal Health to Announce Fourth-Quarter and Year-End Re... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/chmp-has-adopted-a-negative-opinion-on-l... | 06:59 ET
CHMP has adopted a negative opinion on lecanemab for the EU | 06:59 ET | The Committee for Medicinal Products for Human Use (CHMP) of the European Medicin... | | 06:59 ET
CHMP has adopted a negative opinion on lecanemab for the EU | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/chmp-has-adopted-a-negative-opinion-on-l... | 07:05 ET
CHMP has adopted a negative opinion on lecanemab for the EU | 07:05 ET | The Committee for Medicinal Products for Human Use (CHMP) of the European Medicin... | | 07:05 ET
CHMP has adopted a negative opinion on lecanemab for the EU | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/compugen-to-release-second-quarter-2024-... | JUL 23, 2024, 07:00 ET
Compugen to Release Second Quarter 2024 Results on Tuesday... | JUL 23, 2024, 07:00 ET | Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy c... | | JUL 23, 2024, 07:00 ET
Compugen to Release Second Quarter 2024 Results on Tuesday... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/cvs-caremark-defines-future-of-pharmacy-... | | JUL 23, 2024, 10:05 ET | CVS Caremark®, the nation's leading pharmacy benefit manager and a CVS Health® (N... | https://mma.prnewswire.com/media/487051/CVS_Health_Logo.jpg?w=300 | JUL 23, 2024, 10:05 ET
CVS Caremark® defines future of pharmacy benefit managemen... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/eisai-will-seek-re-examination-of-chmp-o... | 07:49 ET
Eisai will seek re-examination of CHMP opinion för lecanemab | 07:49 ET | BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today th... | | 07:49 ET
Eisai will seek re-examination of CHMP opinion för lecanemab | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/eisai-will-seek-re-examination-of-chmp-o... | 07:57 ET
Eisai will seek re-examination of CHMP opinion för lecanemab | 07:57 ET | BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today th... | | 07:57 ET
Eisai will seek re-examination of CHMP opinion för lecanemab | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/elysium-therapeutics-to-present-phase-1-... | | JUL 23, 2024, 08:30 ET | Elysium Therapeutics, an emerging biopharmaceutical company establishing new stan... | https://mma.prnewswire.com/media/2354958/Elysium_Therapeutics_Logo.jpg?w=300 | JUL 23, 2024, 08:30 ET
Elysium Therapeutics to Present Phase 1 Proof-of-Concept R... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/empirx-health-strongly-supports-growing-... | | JUL 23, 2024, 08:00 ET | EmpiRx Health, the leading clinically-driven PBM company, today announced its str... | https://mma.prnewswire.com/media/1336913/EmpiRx_Health_Logo.jpg?w=300 | JUL 23, 2024, 08:00 ET
EmpiRx Health Strongly Supports Growing Congressional and ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/evofem-signs-phexxi-license-agreement-fo... | | JUL 23, 2024, 08:47 ET | Women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFM) and private Emira... | https://mma.prnewswire.com/media/780907/Evofem_Biosciences_Logo.jpg?w=300 | JUL 23, 2024, 08:47 ET
Evofem Signs Phexxi® License Agreement for Middle East wit... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/fda-roundup-july-23-2024-302204512.html | | JUL 23, 2024, 16:03 ET | Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ... | https://mma.prnewswire.com/media/317925/FDA_Logo.jpg?w=300 | JUL 23, 2024, 16:03 ET
FDA Roundup: July 23, 2024 | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/fermenters-and-bioreactors-market-worth-... | | JUL 24, 2024, 06:58 ET | InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report... | https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg?w=300 | JUL 24, 2024, 06:58 ET
Fermenters and Bioreactors Market Worth $43.2 Million by 2... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/fordoz-pharma-corp-announces-fda-approva... | JUL 23, 2024, 09:13 ET
ForDoz Pharma Corp. Announces FDA Approval of DOXOrubicin ... | JUL 23, 2024, 09:13 ET | ForDoz Pharma Corp., a private specialty pharmaceutical company focused on produc... | | JUL 23, 2024, 09:13 ET
ForDoz Pharma Corp. Announces FDA Approval of DOXOrubicin ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/genomma-lab-announces-strategic-bolt-on-... | JUL 25, 2024, 19:11 ET
Genomma Lab Announces Strategic Bolt-On Acquisition of Fou... | JUL 25, 2024, 19:11 ET | Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Comp... | | JUL 25, 2024, 19:11 ET
Genomma Lab Announces Strategic Bolt-On Acquisition of Fou... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/genomma-lab-internacional-announces-resu... | JUL 24, 2024, 19:31 ET
Genomma Lab Internacional Announces Results for the Second... | JUL 24, 2024, 19:31 ET | Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company... | | JUL 24, 2024, 19:31 ET
Genomma Lab Internacional Announces Results for the Second... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/glp-1-market-size-to-reach-usd-95-4-bill... | | JUL 24, 2024, 10:01 ET | InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report... | https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg?w=300 | JUL 24, 2024, 10:01 ET
GLP-1 Market Size to Reach USD 95.4 Billion with a CAGR of... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/halozyme-to-report-second-quarter-2024-f... | | JUL 23, 2024, 08:30 ET | Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will r... | https://mma.prnewswire.com/media/75076/halozyme_therapeutics_logo_Logo.jpg?w=300 | JUL 23, 2024, 08:30 ET
Halozyme to Report Second Quarter 2024 Financial and Opera... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-q2-2024-financi... | | 07:00 ET | HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c... | https://mma.prnewswire.com/media/1806733/logo.jpg?w=300 | 07:00 ET
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/harbour-biomed-to-present-the-latest-pro... | | JUL 25, 2024, 22:16 ET | Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company c... | https://mma.prnewswire.com/media/1096360/HB_for_email_Logo.jpg?w=300 | JUL 25, 2024, 22:16 ET
Harbour BioMed to Present the Latest Progress of the First... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/iaso-bio-announces-nmpa-approval-of-ind-... | JUL 25, 2024, 05:46 ET
IASO Bio Announces NMPA Approval of IND Application for IA... | JUL 25, 2024, 05:46 ET | IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discove... | | JUL 25, 2024, 05:46 ET
IASO Bio Announces NMPA Approval of IND Application for IA... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/immunic-inc-strengthens-its-board-of-dir... | | JUL 24, 2024, 06:30 ET | Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel... | https://mma.prnewswire.com/media/871073/Immunic_Logo.jpg?w=300 | JUL 24, 2024, 06:30 ET
Immunic, Inc. Strengthens Its Board of Directors with the ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/indivior-announces-a-new-100-million-sha... | | JUL 25, 2024, 02:10 ET | Indivior PLC (Nasdaq/LSE: INDV) ("Indivior" or the "Company"), a leading addictio... | https://mma.prnewswire.com/media/1814851/Indivior_Logo.jpg?w=300 | JUL 25, 2024, 02:10 ET
Indivior Announces a New $100 Million Share Repurchase Pro... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/indivior-announces-q2-2024-financial-res... | | JUL 25, 2024, 02:00 ET | Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the per... | https://mma.prnewswire.com/media/1814851/Indivior_Logo.jpg?w=300 | JUL 25, 2024, 02:00 ET
Indivior Announces Q2 2024 Financial Results | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/indivior-announces-q2-2024-financial-res... | | JUL 25, 2024, 02:00 ET | Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the per... | https://mma.prnewswire.com/media/1814851/Indivior_Logo.jpg?w=300 | JUL 25, 2024, 02:00 ET
Indivior Announces Q2 2024 Financial Results | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/innovent-and-wecomput-announce-strategic... | JUL 25, 2024, 21:31 ET
Innovent and WeComput Announce Strategic Partnership to Ad... | JUL 25, 2024, 21:31 ET | Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutica... | | JUL 25, 2024, 21:31 ET
Innovent and WeComput Announce Strategic Partnership to Ad... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/inovio-receives-advanced-therapy-medicin... | | JUL 25, 2024, 16:05 ET | INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercia... | https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg?w=300 | JUL 25, 2024, 16:05 ET
Inovio Receives Advanced Therapy Medicinal Product Certifi... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-2024-fin... | | JUL 25, 2024, 08:00 ET | INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercial... | https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg?w=300 | JUL 25, 2024, 08:00 ET
INOVIO to Report Second Quarter 2024 Financial Results on ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/itf-therapeutics-llc-announces-us-commer... | | JUL 25, 2024, 09:00 ET | ITF Therapeutics LLC, the U.S.-based rare disease commercial arm of Italfarmaco, ... | https://mma.prnewswire.com/media/2468932/ITF_Therapeutics_LLC_logo.jpg?w=300 | JUL 25, 2024, 09:00 ET
ITF Therapeutics LLC Announces U.S. Commercial Availabilit... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-shareholders-elect-... | | JUL 25, 2024, 16:05 ET | Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of a new ind... | https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg?w=300 | JUL 25, 2024, 16:05 ET
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to th... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-... | | JUL 25, 2024, 10:00 ET | Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial... | https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?w=300 | JUL 25, 2024, 10:00 ET
Lilly Confirms Date and Conference Call for Second-Quarter... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/linical-named-best-global-cro-by-global-... | | JUL 23, 2024, 09:00 ET | Linical, a global Contract Research Organization (CRO) for full-service drug deve... | https://mma.prnewswire.com/media/2459781/Brand_Logo_All_Color_Logo_Logo.jpg?w=300... | JUL 23, 2024, 09:00 ET
Linical Named Best Global CRO by Global Health & Pharma Ma... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/loopback-analytics-teams-up-with-loma-li... | | JUL 24, 2024, 11:23 ET | Loopback Analytics, a leading provider of data analytics and market access servic... | https://mma.prnewswire.com/media/2468409/Loopback_Analytics__LoopBack_Analytics_L... | JUL 24, 2024, 11:23 ET
Loopback Analytics Teams Up with Loma Linda University Hea... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-an-acino-company-sign... | | JUL 24, 2024, 09:00 ET | M8 Pharmaceuticals, an Acino company ("M8"), today announces the signature of an ... | https://mma.prnewswire.com/media/2466410/Logo_Acino_fondo_blanco.jpg?w=300 | JUL 24, 2024, 09:00 ET
M8 Pharmaceuticals, an Acino company, Signs Exclusive Agre... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/magenta-medical-closes-105m-financing-le... | | JUL 23, 2024, 07:00 ET | Magenta Medical, developer of Elevate™, the world's smallest heart pump, has clos... | https://mma.prnewswire.com/media/2467106/Magenta_Medical_CEO_Dr_David_Israeli.jpg... | JUL 23, 2024, 07:00 ET
Magenta Medical Closes $105M Financing Led by Novo Holding... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/melanoma-therapeutics-market-to-reach-us... | | JUL 24, 2024, 10:01 ET | The projected development of the global melanoma therapeutics market is estimated... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 24, 2024, 10:01 ET
Melanoma Therapeutics Market to Reach USD 19.2 Billion by ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/merdury-signs-mou-with-health2sync-to-co... | JUL 25, 2024, 03:30 ET
Merdury signs MOU with Health2Sync to conduct trial of Mer... | JUL 25, 2024, 03:30 ET | Merdury Biopharmaceutical Corporation (Merdury) (Taipei Exchange Stock Code: 6932... | | JUL 25, 2024, 03:30 ET
Merdury signs MOU with Health2Sync to conduct trial of Mer... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/molecular-diagnostics-market-worth-32-7-... | | JUL 23, 2024, 10:30 ET | The global Molecular Diagnostics Market is expected to grow from USD 17.3 billion... | https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg?w=300 | JUL 23, 2024, 10:30 ET
Molecular Diagnostics Market worth $32.7 billion by 2029 d... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/myocarditis-treatment-market-size-is-pro... | | JUL 24, 2024, 11:15 ET | The myocarditis treatment market was projected to attain US$ 1.5 billion in 2023.... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 24, 2024, 11:15 ET
Myocarditis Treatment Market Size is Projected to Reach US... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/naltrexone-market-surges-to-usd-30-8-bil... | | JUL 24, 2024, 11:00 ET | The global Naltrexone market stood at US$ 21 billion in 2023, and the global mark... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 24, 2024, 11:00 ET
Naltrexone Market Surges to USD 30.8 Billion by 2034 | Dri... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/nasal-irrigation-market-to-reach-us-1-9-... | | JUL 23, 2024, 05:00 ET | The global nasal irrigation market is estimated to flourish at a CAGR of 18.1% fr... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 23, 2024, 05:00 ET
Nasal Irrigation Market to Reach US$ 1.9 Billion by 2034, ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/nasal-polyposis-treatment-market-to-reac... | | JUL 23, 2024, 05:38 ET | The nasal polyposis treatment market was projected to attain US$ 3.5 billion in 2... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 23, 2024, 05:38 ET
Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 20... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/nova-era-zdravotnej-starostlivosti-v-kaz... | | 06:33 ET | | https://mma.prnewswire.com/media/2469085/1.jpg?w=300 | 06:33 ET
Nová éra zdravotnej starostlivosti v Kazachstane: uvedenie genetického c... | Nová éra zdravotnej starostlivosti v Kazachstane: uvedenie genetického centra Ast... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/nuclearn-reaffirms-commitment-to-the-nuc... | | JUL 24, 2024, 05:00 ET | NuclearN, a leading innovator in the nuclear industry, is proud to highlight its ... | https://mma.prnewswire.com/media/2418850/Square_Artificial_Intelligence___Color_B... | JUL 24, 2024, 05:00 ET
NuclearN Reaffirms Commitment to the Nuclear Industry by H... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/oncolytics-biotech-to-host-conference-ca... | JUL 24, 2024, 07:00 ET
Oncolytics Biotech® to Host Conference Call to Discuss Sec... | JUL 24, 2024, 07:00 ET | Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage comp... | | JUL 24, 2024, 07:00 ET
Oncolytics Biotech® to Host Conference Call to Discuss Sec... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/pantherx-rare-appoints-bansi-nagji-as-ce... | | JUL 25, 2024, 13:00 ET | PANTHERx Rare, one of the nation's largest and fastest growing rare disease speci... | https://mma.prnewswire.com/media/955325/PANTHERx_Rare_Logo.jpg?w=300 | JUL 25, 2024, 13:00 ET
PANTHERx Rare Appoints Bansi Nagji as CEO; Rob Snyder appo... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/pantherxrare-partnering-with-itf-therape... | | JUL 25, 2024, 16:13 ET | PANTHERx® Rare, a leader in rare disease product patient access and support servi... | https://mma.prnewswire.com/media/955325/PANTHERx_Rare_Logo.jpg?w=300 | JUL 25, 2024, 16:13 ET
PANTHERx®Rare Partnering with ITF Therapeutics LLC for U.S... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/pediatric-cardiology-market-to-reach-us-... | | JUL 24, 2024, 05:45 ET | The global pediatric cardiology market is projected to total a valuation of nearl... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 24, 2024, 05:45 ET
Pediatric Cardiology Market to Reach US$ 6.5 Billion by 20... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/piramal-pharma-limited-announces-consoli... | | 06:45 ET | Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceu... | https://mma.prnewswire.com/media/1855206/Piramal_Pharma_Limited_Logo.jpg?w=300 | 06:45 ET
Piramal Pharma Limited Announces Consolidated Results for Q1FY25 | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/piramal-pharma-limited-announces-consoli... | | 06:54 ET | Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceu... | https://mma.prnewswire.com/media/1855206/Piramal_Pharma_Limited_Logo.jpg?w=300 | 06:54 ET
Piramal Pharma Limited Announces Consolidated Results for Q1FY25 | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/platelet-derived-growth-factors-pdgfs-ma... | | JUL 23, 2024, 10:01 ET | The platelet-derived growth factors (PDGFs) market was projected to attain US$ 22... | https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?w=300 | JUL 23, 2024, 10:01 ET
Platelet-derived Growth Factors (PDGFs) Market to Reach US... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/precigen-appoints-phil-tennant-as-chief-... | | JUL 23, 2024, 08:01 ET | Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de... | https://mma.prnewswire.com/media/694013/Precigen_Logo.jpg?w=300 | JUL 23, 2024, 08:01 ET
Precigen Appoints Phil Tennant as Chief Commercial Officer... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/prolacta-bioscience-demonstrates-leaders... | | JUL 24, 2024, 17:45 ET | Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-ba... | https://mma.prnewswire.com/media/1361490/Prolacta_Bioscience_Logo.jpg?w=300 | JUL 24, 2024, 17:45 ET
Prolacta Bioscience Demonstrates Leadership in Human Milk ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/proxsysrx-earns-urac-accreditation-for-s... | JUL 25, 2024, 11:08 ET
ProxsysRx earns URAC Accreditation for specialty pharmacy ... | JUL 25, 2024, 11:08 ET | The ProxsysRx specialty pharmacy team, led by VP Heather Brooks and Compliance & ... | | JUL 25, 2024, 11:08 ET
ProxsysRx earns URAC Accreditation for specialty pharmacy ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call... | JUL 25, 2024, 16:30 ET
PTC Therapeutics to Host Conference Call to Discuss Second... | JUL 25, 2024, 16:30 ET | PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host ... | | JUL 25, 2024, 16:30 ET
PTC Therapeutics to Host Conference Call to Discuss Second... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/quva-pharma-completes-acquisition-of-log... | | JUL 25, 2024, 09:15 ET | QuVa Pharma, Inc. ("QuVa"), announced today the acquisition of LogicStream Health... | https://mma.prnewswire.com/media/525154/Quva_Pharma_Logo.jpg?w=300 | JUL 25, 2024, 09:15 ET
QuVa Pharma Completes Acquisition of LogicStream Health Co... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/ractigen-announces-us-fda-rare-pediatric... | JUL 25, 2024, 08:00 ET
Ractigen Announces U.S. FDA Rare Pediatric Disease Designa... | JUL 25, 2024, 08:00 ET | Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) the... | | JUL 25, 2024, 08:00 ET
Ractigen Announces U.S. FDA Rare Pediatric Disease Designa... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/revolutionary-advances-in-hematological-... | | JUL 25, 2024, 04:32 ET | According to the latest BCC Research study, the demand for "Drugs and Diagnostics... | https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg?w=300 | JUL 25, 2024, 04:32 ET
Revolutionary Advances in Hematological Therapies and Diag... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/ro-welcomes-obesity-research-expert-davi... | JUL 24, 2024, 10:00 ET
Ro Welcomes Obesity Research Expert David B. Allison to it... | JUL 24, 2024, 10:00 ET | Ro, the leading direct-to-patient healthcare company, today announced obesity res... | | JUL 24, 2024, 10:00 ET
Ro Welcomes Obesity Research Expert David B. Allison to it... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/rxlink-and-connectiverx-partner-to-furth... | | JUL 23, 2024, 09:09 ET | RxLink™, a leading provider of medication affordability and price transparency so... | https://mma.prnewswire.com/media/2465518/rxlink_and_connective_rx.jpg?w=300 | JUL 23, 2024, 09:09 ET
RxLink and ConnectiveRx Partner to Further Expand Patient ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/sanyou-bio-congratulates-eluminex-biosci... | 06:00 ET
Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology... | 06:00 ET | On July 15, Eluminex Biosciences announced that their tri-specific fusion antibod... | | 06:00 ET
Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/scinai-immunotherapeutics-announces-posi... | | JUL 23, 2024, 07:00 ET | Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (the "Company"), a biotechnology co... | https://mma.prnewswire.com/media/2310190/Scinai_Immunotherapeutics_Logo.jpg?w=300... | JUL 23, 2024, 07:00 ET
Scinai Immunotherapeutics Announces Positive Regulatory Fe... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/seegene-presenta-i-kit-diagnostici-hpv-e... | | 06:45 ET | | https://mma.prnewswire.com/media/2469787/Seegene_exhibits_booth_demonstrates_HPV_... | 06:45 ET
Seegene presenta i kit diagnostici HPV e la tecnologia PCR all'AOGIN 202... | Seegene presenta i kit diagnostici HPV e la tecnologia PCR all'AOGIN 2024 | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-key-ad... | | JUL 25, 2024, 14:07 ET | Stuart Therapeutics, a clinical-stage ophthalmic biopharmaceutical company focuse... | https://mma.prnewswire.com/media/2469448/Stuart_Florida.jpg?w=300 | JUL 25, 2024, 14:07 ET
Stuart Therapeutics, Inc. Announces Key Addition to its Ex... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/syndax-to-announce-second-quarter-2024-f... | JUL 25, 2024, 07:00 ET
Syndax to Announce Second Quarter 2024 Financial Results a... | JUL 25, 2024, 07:00 ET | Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company... | | JUL 25, 2024, 07:00 ET
Syndax to Announce Second Quarter 2024 Financial Results a... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/telix-announces-a600-million-convertible... | | JUL 23, 2024, 04:35 ET | Telix Pharmaceuticals Limited (ASX: TLX) (Telix, the Company, the Issuer) today l... | https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300 | JUL 23, 2024, 04:35 ET
Telix Announces A$600 Million Convertible Bonds Offering | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-a... | | JUL 25, 2024, 06:00 ET | Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at ... | https://mma.prnewswire.com/media/557290/Theravance_Biopharma_Logo.jpg?w=300 | JUL 25, 2024, 06:00 ET
Theravance Biopharma to Participate in an Upcoming Investo... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/tmrw-life-sciences-offers-2024-united-st... | 08:00 ET
TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic... | 08:00 ET | TMRW Life Sciences (TMRW), a fertility technology company setting a new standard ... | | 08:00 ET
TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic... | | 08:00 ET
TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic... | | TMRW Life Sciences (TMRW), a fertility technology company setting a new standard ... | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/transposon-announces-final-results-from-... | | JUL 24, 2024, 07:00 ET | Transposon Therapeutics, a biotechnology company developing a platform of novel, ... | https://mma.prnewswire.com/media/2275654/Transposon_Therapeutics_Logo.jpg?w=300 | JUL 24, 2024, 07:00 ET
Transposon Announces Final Results from a Phase 2 Study of... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/true-rx-health-strategists-launches-coll... | JUL 23, 2024, 09:00 ET
TRUE Rx HEALTH STRATEGISTS LAUNCHES COLLABORATION WITH MAR... | JUL 23, 2024, 09:00 ET | True Rx Health Strategists, the Indiana-based pharmacy benefit management (PBM) c... | | JUL 23, 2024, 09:00 ET
TRUE Rx HEALTH STRATEGISTS LAUNCHES COLLABORATION WITH MAR... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/us-fda--approves-leqselvi-deuruxolitinib... | | JUL 25, 2024, 20:09 ET | Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: ... | https://mma.prnewswire.com/media/2469577/Sun_Pharma_Logo.jpg?w=300 | JUL 25, 2024, 20:09 ET
U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK ... | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/valinor-pharma-annonce-son-acquisition-p... | JUL 23, 2024, 10:04 ET
Valinor Pharma annonce son acquisition par Grünenthal pour... | JUL 23, 2024, 10:04 ET | | | JUL 23, 2024, 10:04 ET
Valinor Pharma annonce son acquisition par Grünenthal pour... | Valinor Pharma annonce son acquisition par Grünenthal pour une valeur totale d'en... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/valinor-pharma-kundigt-ubernahme-durch-g... | JUL 23, 2024, 09:48 ET
Valinor Pharma kündigt Übernahme durch Grünenthal mit eine... | JUL 23, 2024, 09:48 ET | | | JUL 23, 2024, 09:48 ET
Valinor Pharma kündigt Übernahme durch Grünenthal mit eine... | Valinor Pharma kündigt Übernahme durch Grünenthal mit einem Gesamtwert von ca. 25... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/valinor-pharma-ogasza-e-zostaa-przejta-p... | JUL 23, 2024, 11:16 ET
Valinor Pharma ogłasza, że została przejęta przez spółkę G... | JUL 23, 2024, 11:16 ET | | | JUL 23, 2024, 11:16 ET
Valinor Pharma ogłasza, że została przejęta przez spółkę G... | Valinor Pharma ogłasza, że została przejęta przez spółkę Grünenthal w ramach tran... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/valinor-pharma-oznamuje-akvizici-spoleno... | JUL 23, 2024, 09:38 ET
Valinor Pharma oznamuje akvizici společností Grünenthal v ... | JUL 23, 2024, 09:38 ET | | | JUL 23, 2024, 09:38 ET
Valinor Pharma oznamuje akvizici společností Grünenthal v ... | Valinor Pharma oznamuje akvizici společností Grünenthal v transakci o celkové hod... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/valinor-pharma-oznamuje-akviziciu-spolon... | JUL 23, 2024, 10:23 ET
Valinor Pharma oznamuje akvizíciu spoločnosťou Grünenthal ... | JUL 23, 2024, 10:23 ET | | | JUL 23, 2024, 10:23 ET
Valinor Pharma oznamuje akvizíciu spoločnosťou Grünenthal ... | Valinor Pharma oznamuje akvizíciu spoločnosťou Grünenthal v celkovej hodnote prib... | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |
https://www.prnewswire.com/news-releases/west-announces-second-quarter-2024-resul... | | JUL 25, 2024, 06:00 ET | West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial resu... | https://mma.prnewswire.com/media/890850/west_pharma_large_Logo.jpg?w=300 | JUL 25, 2024, 06:00 ET
West Announces Second-Quarter 2024 Results | | | | | | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC | 2024-07-26 12:18:32 UTC |